Jaguar Health Files 8-K on Material Agreement
Ticker: JAGX · Form: 8-K · Filed: 2025-08-14T00:00:00.000Z
Sentiment: neutral
Topics: material-agreement, filing
TL;DR
Jaguar Health signed a big deal, filing an 8-K on Aug 14, 2025.
AI Summary
On August 14, 2025, Jaguar Health, Inc. filed an 8-K report detailing a material definitive agreement. The filing also includes financial statements and exhibits related to this agreement. The company, formerly known as Jaguar Animal Health, Inc., is incorporated in Delaware and headquartered in San Francisco, California.
Why It Matters
This filing indicates a significant new contract or partnership for Jaguar Health, Inc., which could impact its future operations and financial performance.
Risk Assessment
Risk Level: medium — Material definitive agreements can introduce new risks or opportunities, the specifics of which are not detailed in this initial 8-K filing.
Key Players & Entities
- Jaguar Health, Inc. (company) — Registrant
- August 14, 2025 (date) — Date of earliest event reported
- Jaguar Animal Health, Inc. (company) — Former company name
- Delaware (jurisdiction) — State of incorporation
- San Francisco, California (location) — Address of Principal Executive Offices
FAQ
What is the nature of the material definitive agreement filed by Jaguar Health, Inc.?
The filing indicates the entry into a material definitive agreement, but the specific details of the agreement are not provided in the provided text.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on August 14, 2025.
What was Jaguar Health, Inc.'s former company name?
Jaguar Health, Inc.'s former company name was Jaguar Animal Health, Inc.
In which state is Jaguar Health, Inc. incorporated?
Jaguar Health, Inc. is incorporated in Delaware.
What is the address of Jaguar Health, Inc.'s principal executive offices?
The address of Jaguar Health, Inc.'s principal executive offices is 200 Pine Street Suite 400, San Francisco, California, 94104.
Filing Stats: 701 words · 3 min read · ~2 pages · Grade level 11.7 · Accepted 2025-08-14 09:44:04
Key Financial Figures
- $0.0001 — ich registered Common Stock, Par Value $0.0001 Per Share JAGX The Nasdaq Stock Mar
Filing Documents
- d795256d8k.htm (8-K) — 25KB
- d795256dex101.htm (EX-10.1) — 10KB
- 0001193125-25-180438.txt ( ) — 150KB
- jagx-20250814.xsd (EX-101.SCH) — 3KB
- jagx-20250814_lab.xml (EX-101.LAB) — 18KB
- jagx-20250814_pre.xml (EX-101.PRE) — 11KB
- d795256d8k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. JAGUAR HEALTH, INC. Date: August 14, 2025 By: /s/ Lisa A. Conte Lisa A. Conte President and Chief Executive Officer